Literature DB >> 4482

Adherence of serotype e Streptococcus mutans and the inhibitory effect of Lancefield group E and S mutans type e antiserum.

S Hamada, H D Slade.   

Abstract

S mutans strain MT703 from an active carious lesion in the tooth of a child had type e specificity and showed a cross-reaction with the Lancefield group E cell wall streptococcal polysaccharide antigen. Heat-killed cells MT703 adhered to a glass surface in the presence of CGT MT703 and sucrose. Pretreatment of the cells with anti-MT703 whole cell serums inhibited adherecne. The removal of glycerol teichoic acid antibody and group E antibody from the MT703 serum did not result in a loss of inhibitory activity. Antiserum with or without adsorption significantly inhibited glucan synthesis by CGT from sucrose. Antibodies specific for the polyglycerol phosphate of teichoic acid did not inhibit adherence. Anti-group E serum and serums specific for other types of S mutans, did not show adherence inhibitory activity except for an occasional type c specific antiserum. Antibody specific for the type e antigen produced significant inhibition of the binding of CGT to the MT703 cell wall, and adherence of these cells did not occur. Antibody to CGT inhibited glucan synthesis. Treatment of the cells with dextranase, dextran antibody, or trypsin caused a significant reduction in adherence. The results suggest that the type antigen and dextran on the surface of the S mutans type e cell are functional in adherence, and that these polymers are associated with cell wall protein.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4482     DOI: 10.1177/002203457605500328011

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  12 in total

1.  Bacterial and strain specificities in opsonization, phagocytosis and killing of Streptococcus mutans.

Authors:  C M Scully; T Lehner
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

2.  Binding of lectins to Streptococcus mutans cells and type-specific polysaccharides, and effect on adherence.

Authors:  S Hamada; K Gill; H D Slade
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

3.  Factors influencing adherence of group B streptococci to human vaginal epithelial cells.

Authors:  S M Zawaneh; E M Ayoub; H Baer; A C Cruz; W N Spellacy
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

4.  Extractability of cell wall polysaccharide from lactobacilli and streptococci by autoclaving and by dilue acid.

Authors:  L K Campbell; K W Knox; A J Wicken
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

5.  Properties of Streptococcus mutans grown in a synthetic medium: binding of glucosyltransferase and in vitro adherence, and binding of dextran/glucan and glycoprotein and agglutination.

Authors:  C D Wu-Yuan; S Tai; H D Slade
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

6.  Selective adsorption of heterophile polyglycerophosphate antigen from antigen extracts of Streptococcus mutans and other gram-positive bacteria.

Authors:  S Hamada; S Tai; H D Slade
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

7.  Chemical and immunological properties of the type f polysaccharide antigen of Streptococcus mutans.

Authors:  S Hamada; K Gill; H D Slade
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

8.  Purification and immunochemical characterization of type e polysaccharide antigen of Streptococcus mutans.

Authors:  S Hamada; H D Slade
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

9.  Binding of glucosyltransferase and glucan synthesis by Streptococcus mutans and other bacteria.

Authors:  S Hamada; S Tai; H D Slade
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

10.  Production of monoclonal antibody against a glucosyltransferase of Streptococcus mutans 6715.

Authors:  T Furuta; T Nisizawa; J Chiba; S Hamada
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.